Mar 10, 2020
Study Shows CRISPR Effectiveness Against Colitis Pathogen
Research at North Carolina State University shows that the CRISPR-Cas system can be used to effectively target and eliminate specific gut bacteria, in this case Clostridioides difficile, the pathogen that causes colitis – a chronic, degenerative disease of the colon.